XNAS · ATRC
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
AtriCure, Inc.

AtriCure, Inc.

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$31.79

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is ATRC moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About AtriCure, Inc.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2005
Employees
1K
Country
US

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$31.79
Last session
Day high
$31.79
Last session
Day low
$31.79
Last session
Previous close
$31.79
52W high
$31.79
0.00% from high
52W low
$27.07
100% of range
Market cap
$1.6B
EPS
$-0.2800
Shares out
50.6M
VWAP
$31.79
Last session
Price history computed in-house
1W
+5.34%
SMA 50 $28.74 · above
SMA 200 $28.74 · above
52W position 100%
Veridion warehouse edge

Warehouse intelligence for ATRC.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

ATRC insider activity

AtriCure, Inc.

Score
Coverage building
Pressure
Net selling
Filings
26
Buys / sells
7 / 19
Net value
-$6.6M
Insiders
12
Named filers
PK
Prange Karen
Insider
Leadership
DV
Doraiswamy Vinayak
Insider
Leadership
WS
WHITE ROBERT S.
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$6.6M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-05-222026-05-20Prange KarenInsidersell$28.653,00026,373$86KSEC Form 4
2026-05-182026-05-15Doraiswamy VinayakInsidersell$28.135,00091,875$141KSEC Form 4
2026-03-162026-03-12Doraiswamy VinayakInsidersell$29.835,00096,875$149KSEC Form 4
2026-03-122026-03-10WHITE ROBERT S.Insiderbuy$14.9910,000Not reported$150KSEC Form 4
2026-03-122026-03-10WHITE ROBERT S.Insiderbuy$14.9910,000122,174$150KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 21 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

ATRC contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ATRC in this window.
Lobbying spend

ATRC lobbying filings, year to date.

Registered lobbying filings matched to AtriCure, Inc..

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ATRC in this window.
Latest news · ATRC
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for ATRC.
Options
Sovereign unlock shows live options positioning for ATRC.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.